tirzepatide court decision FDA confirms shortage is still over, gives compounders a grace period court decision on tirzepatide U.S.

Cost Comparison Summary Strategies for Reducing Mounjaro Costs Heres how to find the best price for your situation

Lilly PACKAGE LABEL - Zepbound Multi-Dose Vial - 15 mg/0.6 mL Dose (60 mg/2.4 mL [25 mg/mL]) Rx Only NDC 0002-6612-11 Zepbound (tirzepatide) injection 60 mg/2.4 mL (25 mg/mL) ATTENTION: Contains 4 doses of 15 mg/0.6 mL 2.4 mL MULTI-DOSE VIAL For Subcutaneous Use Needles and Syringes are not included Dispense enclosed Medication Guide to each patient

Compounded semaglutide is not FDA-approved as a finished drug product, but it is legally produced under federal and state oversight when sourced from registered 503B facilities

Pharmacies should work with prescribers to ensure individualized, clinically supported documentation is in place for each patient